-

Australia Neurology Procedures Outlook to 2025 - Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures & ICP Procedures - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Neurology Procedures Outlook to 2025 - Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others." report has been added to ResearchAndMarkets.com's offering.

Summary

The publisher's new report, Australia Neurology Procedures Outlook to 2025, provides key procedures data on the Australia Neurology Procedures. The report provides procedure volumes within market segments - Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, Neurovascular Embolization Procedures, Neurovascular Coiling Assist Procedures, Neurovascular Accessory Procedures, Intracranial Stenting Procedures, ICP Procedures, Dura Substitute Procedures, Neuromodulation Procedures and Minimally Invasive Neurosurgery Procedures.

The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

  • Australia Neurology Procedures volumes by segments Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, Neurovascular Embolization Procedures, Neurovascular Coiling Assist Procedures, Neurovascular Accessory Procedures, Intracranial Stenting Procedures, ICP Procedures, Dura Substitute Procedures, Neuromodulation Procedures and Minimally Invasive Neurosurgery Procedures.
  • Projections for each of the market segments. Data is provided from 2015 to 2025.
  • Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Develop market-entry and market expansion strategies.

Reasons to buy

  • Develop business and investment strategies by identifying the key market segment expected to register strong growth in the near future.
  • Develop market-entry and market expansion strategies.

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Neurology Procedures Segmentation

2.3 Definitions of Procedures Covered in the Report

3 Neurology Procedures, Australia

3.1 Neurology Procedures, Australia, 2015-2025

3.2 Neurology Procedures, Australia, 2015-2025

4 Dura Substitute Procedures, Australia

4.1 Dura Substitute Procedures, Australia, 2015-2025

5 Hydrocephalus Shunting Procedures, Australia

5.1 Hydrocephalus Shunting Procedures, Australia, 2015-2025

5.1.1 Revision Hydrocephalus Shunts Procedures, Australia, 2015-2025

6 ICP Procedures, Australia

6.1 ICP Procedures, Australia, 2015-2025

7 Intracranial Stenting Procedures, Australia

7.1 Intracranial Stenting Procedures, Australia, 2015-2025

8 Minimally Invasive Neurosurgery Procedures, Australia

8.1 Minimally Invasive Neurosurgery Procedures, Australia, 2015-2025

8.1.1 Minimally Invasive Neurosurgical Devices Procedures, Australia, 2015-2025

9 Neuromodulation Procedures, Australia

9.1 Neuromodulation Procedures, Australia, 2015-2025

10 Neurovascular Accessory Procedures, Australia

10.1 Neurovascular Accessory Procedures, Australia, 2015-2025

11 Neurovascular Coiling Assist Procedures, Australia

11.1 Neurovascular Coiling Assist Procedures, Australia, 2015-2025

12 Neurovascular Embolization Procedures, Australia

12.1 Neurovascular Embolization Procedures, Australia, 2015-2025

12.1.1 Flow Diversion Stent Procedures, Australia, 2015-2025

13 Neurovascular Thrombectomy Procedures, Australia

13.1 Neurovascular Thrombectomy Procedures, Australia, 2015-2025

14 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/iwjqe

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Pharmaceutical Regulatory Affairs in Asia Training Course: Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (Mar 24th - Mar 26th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th - Mar 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries....

European Union Veterinary Pharmacovigilance Introductory Training Course: Practical Guidance and Basic Training for All Those Working in Drug Safety (Mar 9th - Mar 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to Veterinary Pharmacovigilance Training Course (Mar 9th - Mar 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day event has been designed to provide an essential overview of veterinary pharmacovigilance and will offer practical guidance and basic training for all those working in drug safety in the EU. Our experienced trainer will clarify roles and responsibilities, explain commonly used terminology and take partici...

Pharma and Medical Device Clinical Quality Management Systems Training Course: EMA Guidance on Computerised Systems and ICH GCP R3 Data Governance (Mar 23rd - Mar 24th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Quality Management Systems Training Course (Mar 23rd - Mar 24th, 2026)" training has been added to ResearchAndMarkets.com's offering. This course will provide essential information and guidance to help you achieve regulatory compliance in this evolving area of clinical quality, including EMA guidance on computerised systems and ICH GCP R3 data governance. With increasing clinical quality standards required by inspectors, there is currently no harmonised re...
Back to Newsroom